nodes	percent_of_prediction	percent_of_DWPC	metapath
Rifabutin—CYP1A2—Dacarbazine—pancreatic cancer	0.0859	0.209	CbGbCtD
Rifabutin—CYP1A2—Tamoxifen—pancreatic cancer	0.0683	0.166	CbGbCtD
Rifabutin—CYP1A2—Erlotinib—pancreatic cancer	0.0581	0.141	CbGbCtD
Rifabutin—CYP1A2—Fluorouracil—pancreatic cancer	0.0503	0.122	CbGbCtD
Rifabutin—CYP3A4—Tamoxifen—pancreatic cancer	0.0358	0.087	CbGbCtD
Rifabutin—CYP3A4—Erlotinib—pancreatic cancer	0.0304	0.0739	CbGbCtD
Rifabutin—CYP3A4—Irinotecan—pancreatic cancer	0.0275	0.0668	CbGbCtD
Rifabutin—CYP3A4—Docetaxel—pancreatic cancer	0.0201	0.0489	CbGbCtD
Rifabutin—CYP3A4—Sunitinib—pancreatic cancer	0.02	0.0487	CbGbCtD
Rifabutin—HSP90B1—gall bladder—pancreatic cancer	0.0161	0.222	CbGeAlD
Rifabutin—CYP3A4—Doxorubicin—pancreatic cancer	0.015	0.0365	CbGbCtD
Rifabutin—HSP90AA1—gall bladder—pancreatic cancer	0.0118	0.162	CbGeAlD
Rifabutin—HSP90B1—islet of Langerhans—pancreatic cancer	0.0105	0.145	CbGeAlD
Rifabutin—HSP90AA1—islet of Langerhans—pancreatic cancer	0.00771	0.106	CbGeAlD
Rifabutin—HSP90B1—pancreas—pancreatic cancer	0.00741	0.102	CbGeAlD
Rifabutin—HSP90B1—digestive system—pancreatic cancer	0.00633	0.0873	CbGeAlD
Rifabutin—HSP90AA1—pancreas—pancreatic cancer	0.00542	0.0748	CbGeAlD
Rifabutin—HSP90AA1—digestive system—pancreatic cancer	0.00463	0.0639	CbGeAlD
Rifabutin—CYP1A2—digestive system—pancreatic cancer	0.0015	0.0206	CbGeAlD
Rifabutin—CYP3A4—digestive system—pancreatic cancer	0.00108	0.0149	CbGeAlD
Rifabutin—Musculoskeletal discomfort—Sunitinib—pancreatic cancer	0.000539	0.00197	CcSEcCtD
Rifabutin—Anaemia—Gemcitabine—pancreatic cancer	0.000537	0.00197	CcSEcCtD
Rifabutin—Insomnia—Sunitinib—pancreatic cancer	0.000535	0.00196	CcSEcCtD
Rifabutin—Leukopenia—Irinotecan—pancreatic cancer	0.000534	0.00196	CcSEcCtD
Rifabutin—Blood alkaline phosphatase increased—Epirubicin—pancreatic cancer	0.000531	0.00195	CcSEcCtD
Rifabutin—Paraesthesia—Sunitinib—pancreatic cancer	0.000531	0.00194	CcSEcCtD
Rifabutin—Anaemia—Fluorouracil—pancreatic cancer	0.000528	0.00193	CcSEcCtD
Rifabutin—Dyspnoea—Sunitinib—pancreatic cancer	0.000527	0.00193	CcSEcCtD
Rifabutin—Dyspepsia—Sunitinib—pancreatic cancer	0.00052	0.00191	CcSEcCtD
Rifabutin—Leukopenia—Gemcitabine—pancreatic cancer	0.00052	0.00191	CcSEcCtD
Rifabutin—Jaundice—Docetaxel—pancreatic cancer	0.000514	0.00188	CcSEcCtD
Rifabutin—Decreased appetite—Sunitinib—pancreatic cancer	0.000514	0.00188	CcSEcCtD
Rifabutin—Leukopenia—Fluorouracil—pancreatic cancer	0.000511	0.00187	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Sunitinib—pancreatic cancer	0.00051	0.00187	CcSEcCtD
Rifabutin—Hypersensitivity—Tamoxifen—pancreatic cancer	0.000508	0.00186	CcSEcCtD
Rifabutin—Pain—Sunitinib—pancreatic cancer	0.000505	0.00185	CcSEcCtD
Rifabutin—Hepatobiliary disease—Docetaxel—pancreatic cancer	0.000499	0.00183	CcSEcCtD
Rifabutin—Asthenia—Tamoxifen—pancreatic cancer	0.000495	0.00181	CcSEcCtD
Rifabutin—Convulsion—Fluorouracil—pancreatic cancer	0.000495	0.00181	CcSEcCtD
Rifabutin—Chest pain—Gemcitabine—pancreatic cancer	0.000495	0.00181	CcSEcCtD
Rifabutin—Arthralgia—Gemcitabine—pancreatic cancer	0.000495	0.00181	CcSEcCtD
Rifabutin—Myalgia—Gemcitabine—pancreatic cancer	0.000495	0.00181	CcSEcCtD
Rifabutin—Agranulocytosis—Docetaxel—pancreatic cancer	0.000492	0.0018	CcSEcCtD
Rifabutin—Blood alkaline phosphatase increased—Doxorubicin—pancreatic cancer	0.000491	0.0018	CcSEcCtD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—pancreatic cancer	0.000491	0.0018	CcSEcCtD
Rifabutin—Confusional state—Irinotecan—pancreatic cancer	0.000491	0.0018	CcSEcCtD
Rifabutin—Asthenia—Erlotinib—pancreatic cancer	0.00049	0.00179	CcSEcCtD
Rifabutin—Pruritus—Tamoxifen—pancreatic cancer	0.000488	0.00179	CcSEcCtD
Rifabutin—Myalgia—Fluorouracil—pancreatic cancer	0.000486	0.00178	CcSEcCtD
Rifabutin—Chest pain—Fluorouracil—pancreatic cancer	0.000486	0.00178	CcSEcCtD
Rifabutin—Gastrointestinal pain—Sunitinib—pancreatic cancer	0.000483	0.00177	CcSEcCtD
Rifabutin—Pruritus—Erlotinib—pancreatic cancer	0.000483	0.00177	CcSEcCtD
Rifabutin—Shock—Irinotecan—pancreatic cancer	0.000479	0.00175	CcSEcCtD
Rifabutin—Thrombocytopenia—Irinotecan—pancreatic cancer	0.000477	0.00175	CcSEcCtD
Rifabutin—Hepatitis—Docetaxel—pancreatic cancer	0.000474	0.00174	CcSEcCtD
Rifabutin—Diarrhoea—Tamoxifen—pancreatic cancer	0.000472	0.00173	CcSEcCtD
Rifabutin—Confusional state—Fluorouracil—pancreatic cancer	0.00047	0.00172	CcSEcCtD
Rifabutin—Abdominal pain—Sunitinib—pancreatic cancer	0.000467	0.00171	CcSEcCtD
Rifabutin—Body temperature increased—Sunitinib—pancreatic cancer	0.000467	0.00171	CcSEcCtD
Rifabutin—Diarrhoea—Erlotinib—pancreatic cancer	0.000467	0.00171	CcSEcCtD
Rifabutin—Connective tissue disorder—Docetaxel—pancreatic cancer	0.000466	0.00171	CcSEcCtD
Rifabutin—Thrombocytopenia—Gemcitabine—pancreatic cancer	0.000464	0.0017	CcSEcCtD
Rifabutin—Anorexia—Irinotecan—pancreatic cancer	0.000464	0.0017	CcSEcCtD
Rifabutin—Skin disorder—Gemcitabine—pancreatic cancer	0.000461	0.00169	CcSEcCtD
Rifabutin—Thrombocytopenia—Fluorouracil—pancreatic cancer	0.000457	0.00167	CcSEcCtD
Rifabutin—Anorexia—Gemcitabine—pancreatic cancer	0.000452	0.00166	CcSEcCtD
Rifabutin—Anorexia—Fluorouracil—pancreatic cancer	0.000445	0.00163	CcSEcCtD
Rifabutin—Eye disorder—Docetaxel—pancreatic cancer	0.000443	0.00162	CcSEcCtD
Rifabutin—Insomnia—Irinotecan—pancreatic cancer	0.00044	0.00161	CcSEcCtD
Rifabutin—Vomiting—Tamoxifen—pancreatic cancer	0.000439	0.00161	CcSEcCtD
Rifabutin—Paraesthesia—Irinotecan—pancreatic cancer	0.000437	0.0016	CcSEcCtD
Rifabutin—Hypersensitivity—Sunitinib—pancreatic cancer	0.000436	0.0016	CcSEcCtD
Rifabutin—Rash—Tamoxifen—pancreatic cancer	0.000435	0.00159	CcSEcCtD
Rifabutin—Dermatitis—Tamoxifen—pancreatic cancer	0.000435	0.00159	CcSEcCtD
Rifabutin—Vomiting—Erlotinib—pancreatic cancer	0.000434	0.00159	CcSEcCtD
Rifabutin—Dyspnoea—Irinotecan—pancreatic cancer	0.000434	0.00159	CcSEcCtD
Rifabutin—Headache—Tamoxifen—pancreatic cancer	0.000432	0.00158	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	0.000432	0.00158	CcSEcCtD
Rifabutin—Rash—Erlotinib—pancreatic cancer	0.000431	0.00158	CcSEcCtD
Rifabutin—Dermatitis—Erlotinib—pancreatic cancer	0.00043	0.00158	CcSEcCtD
Rifabutin—Insomnia—Gemcitabine—pancreatic cancer	0.000429	0.00157	CcSEcCtD
Rifabutin—Dyspepsia—Irinotecan—pancreatic cancer	0.000429	0.00157	CcSEcCtD
Rifabutin—Immune system disorder—Docetaxel—pancreatic cancer	0.000428	0.00157	CcSEcCtD
Rifabutin—Headache—Erlotinib—pancreatic cancer	0.000428	0.00157	CcSEcCtD
Rifabutin—Paraesthesia—Gemcitabine—pancreatic cancer	0.000426	0.00156	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.000425	0.00156	CcSEcCtD
Rifabutin—Asthenia—Sunitinib—pancreatic cancer	0.000424	0.00155	CcSEcCtD
Rifabutin—Decreased appetite—Irinotecan—pancreatic cancer	0.000423	0.00155	CcSEcCtD
Rifabutin—Dyspnoea—Gemcitabine—pancreatic cancer	0.000423	0.00155	CcSEcCtD
Rifabutin—Insomnia—Fluorouracil—pancreatic cancer	0.000422	0.00154	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.00042	0.00154	CcSEcCtD
Rifabutin—Paraesthesia—Fluorouracil—pancreatic cancer	0.000419	0.00153	CcSEcCtD
Rifabutin—Pruritus—Sunitinib—pancreatic cancer	0.000418	0.00153	CcSEcCtD
Rifabutin—Pain—Irinotecan—pancreatic cancer	0.000416	0.00153	CcSEcCtD
Rifabutin—Aspartate aminotransferase increased—Epirubicin—pancreatic cancer	0.000416	0.00152	CcSEcCtD
Rifabutin—Dyspnoea—Fluorouracil—pancreatic cancer	0.000416	0.00152	CcSEcCtD
Rifabutin—Decreased appetite—Gemcitabine—pancreatic cancer	0.000412	0.00151	CcSEcCtD
Rifabutin—Dyspepsia—Fluorouracil—pancreatic cancer	0.00041	0.0015	CcSEcCtD
Rifabutin—Nausea—Tamoxifen—pancreatic cancer	0.00041	0.0015	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000409	0.0015	CcSEcCtD
Rifabutin—Alanine aminotransferase increased—Epirubicin—pancreatic cancer	0.000407	0.00149	CcSEcCtD
Rifabutin—Pain—Gemcitabine—pancreatic cancer	0.000406	0.00149	CcSEcCtD
Rifabutin—Nausea—Erlotinib—pancreatic cancer	0.000406	0.00149	CcSEcCtD
Rifabutin—Decreased appetite—Fluorouracil—pancreatic cancer	0.000405	0.00148	CcSEcCtD
Rifabutin—Diarrhoea—Sunitinib—pancreatic cancer	0.000404	0.00148	CcSEcCtD
Rifabutin—Dysgeusia—Docetaxel—pancreatic cancer	0.000404	0.00148	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000403	0.00147	CcSEcCtD
Rifabutin—Feeling abnormal—Irinotecan—pancreatic cancer	0.000401	0.00147	CcSEcCtD
Rifabutin—Pain—Fluorouracil—pancreatic cancer	0.000399	0.00146	CcSEcCtD
Rifabutin—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000398	0.00146	CcSEcCtD
Rifabutin—Eosinophilia—Epirubicin—pancreatic cancer	0.000395	0.00145	CcSEcCtD
Rifabutin—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000391	0.00143	CcSEcCtD
Rifabutin—Body temperature increased—Irinotecan—pancreatic cancer	0.000385	0.00141	CcSEcCtD
Rifabutin—Abdominal pain—Irinotecan—pancreatic cancer	0.000385	0.00141	CcSEcCtD
Rifabutin—Aspartate aminotransferase increased—Doxorubicin—pancreatic cancer	0.000385	0.00141	CcSEcCtD
Rifabutin—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000384	0.00141	CcSEcCtD
Rifabutin—Anaemia—Docetaxel—pancreatic cancer	0.000381	0.0014	CcSEcCtD
Rifabutin—Pancytopenia—Epirubicin—pancreatic cancer	0.000379	0.00139	CcSEcCtD
Rifabutin—Alanine aminotransferase increased—Doxorubicin—pancreatic cancer	0.000377	0.00138	CcSEcCtD
Rifabutin—Vomiting—Sunitinib—pancreatic cancer	0.000376	0.00138	CcSEcCtD
Rifabutin—Body temperature increased—Gemcitabine—pancreatic cancer	0.000375	0.00137	CcSEcCtD
Rifabutin—Neutropenia—Epirubicin—pancreatic cancer	0.000373	0.00137	CcSEcCtD
Rifabutin—Rash—Sunitinib—pancreatic cancer	0.000373	0.00137	CcSEcCtD
Rifabutin—Dermatitis—Sunitinib—pancreatic cancer	0.000372	0.00136	CcSEcCtD
Rifabutin—Headache—Sunitinib—pancreatic cancer	0.00037	0.00136	CcSEcCtD
Rifabutin—Leukopenia—Docetaxel—pancreatic cancer	0.000369	0.00135	CcSEcCtD
Rifabutin—Body temperature increased—Fluorouracil—pancreatic cancer	0.000369	0.00135	CcSEcCtD
Rifabutin—Eosinophilia—Doxorubicin—pancreatic cancer	0.000366	0.00134	CcSEcCtD
Rifabutin—Hypersensitivity—Irinotecan—pancreatic cancer	0.000359	0.00131	CcSEcCtD
Rifabutin—Convulsion—Docetaxel—pancreatic cancer	0.000357	0.00131	CcSEcCtD
Rifabutin—Myalgia—Docetaxel—pancreatic cancer	0.000351	0.00129	CcSEcCtD
Rifabutin—Chest pain—Docetaxel—pancreatic cancer	0.000351	0.00129	CcSEcCtD
Rifabutin—Arthralgia—Docetaxel—pancreatic cancer	0.000351	0.00129	CcSEcCtD
Rifabutin—Nausea—Sunitinib—pancreatic cancer	0.000351	0.00129	CcSEcCtD
Rifabutin—Pancytopenia—Doxorubicin—pancreatic cancer	0.000351	0.00128	CcSEcCtD
Rifabutin—Asthenia—Irinotecan—pancreatic cancer	0.000349	0.00128	CcSEcCtD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000349	0.00128	CcSEcCtD
Rifabutin—Jaundice—Epirubicin—pancreatic cancer	0.000347	0.00127	CcSEcCtD
Rifabutin—Neutropenia—Doxorubicin—pancreatic cancer	0.000345	0.00127	CcSEcCtD
Rifabutin—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000344	0.00126	CcSEcCtD
Rifabutin—Asthenia—Gemcitabine—pancreatic cancer	0.00034	0.00125	CcSEcCtD
Rifabutin—Confusional state—Docetaxel—pancreatic cancer	0.000339	0.00124	CcSEcCtD
Rifabutin—Hepatobiliary disease—Epirubicin—pancreatic cancer	0.000337	0.00123	CcSEcCtD
Rifabutin—Pruritus—Gemcitabine—pancreatic cancer	0.000336	0.00123	CcSEcCtD
Rifabutin—Diarrhoea—Irinotecan—pancreatic cancer	0.000333	0.00122	CcSEcCtD
Rifabutin—Agranulocytosis—Epirubicin—pancreatic cancer	0.000332	0.00122	CcSEcCtD
Rifabutin—Shock—Docetaxel—pancreatic cancer	0.000331	0.00121	CcSEcCtD
Rifabutin—Pruritus—Fluorouracil—pancreatic cancer	0.00033	0.00121	CcSEcCtD
Rifabutin—Thrombocytopenia—Docetaxel—pancreatic cancer	0.00033	0.00121	CcSEcCtD
Rifabutin—Skin disorder—Docetaxel—pancreatic cancer	0.000327	0.0012	CcSEcCtD
Rifabutin—Diarrhoea—Gemcitabine—pancreatic cancer	0.000325	0.00119	CcSEcCtD
Rifabutin—Jaundice—Doxorubicin—pancreatic cancer	0.000321	0.00118	CcSEcCtD
Rifabutin—Anorexia—Docetaxel—pancreatic cancer	0.000321	0.00118	CcSEcCtD
Rifabutin—Hepatitis—Epirubicin—pancreatic cancer	0.00032	0.00117	CcSEcCtD
Rifabutin—Diarrhoea—Fluorouracil—pancreatic cancer	0.000319	0.00117	CcSEcCtD
Rifabutin—Connective tissue disorder—Epirubicin—pancreatic cancer	0.000314	0.00115	CcSEcCtD
Rifabutin—Hepatobiliary disease—Doxorubicin—pancreatic cancer	0.000311	0.00114	CcSEcCtD
Rifabutin—Vomiting—Irinotecan—pancreatic cancer	0.00031	0.00113	CcSEcCtD
Rifabutin—Agranulocytosis—Doxorubicin—pancreatic cancer	0.000307	0.00113	CcSEcCtD
Rifabutin—Rash—Irinotecan—pancreatic cancer	0.000307	0.00112	CcSEcCtD
Rifabutin—Dermatitis—Irinotecan—pancreatic cancer	0.000307	0.00112	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000307	0.00112	CcSEcCtD
Rifabutin—Headache—Irinotecan—pancreatic cancer	0.000305	0.00112	CcSEcCtD
Rifabutin—Insomnia—Docetaxel—pancreatic cancer	0.000304	0.00112	CcSEcCtD
Rifabutin—Paraesthesia—Docetaxel—pancreatic cancer	0.000302	0.00111	CcSEcCtD
Rifabutin—Vomiting—Gemcitabine—pancreatic cancer	0.000302	0.0011	CcSEcCtD
Rifabutin—Dyspnoea—Docetaxel—pancreatic cancer	0.0003	0.0011	CcSEcCtD
Rifabutin—Rash—Gemcitabine—pancreatic cancer	0.000299	0.0011	CcSEcCtD
Rifabutin—Dermatitis—Gemcitabine—pancreatic cancer	0.000299	0.00109	CcSEcCtD
Rifabutin—Eye disorder—Epirubicin—pancreatic cancer	0.000299	0.00109	CcSEcCtD
Rifabutin—Headache—Gemcitabine—pancreatic cancer	0.000297	0.00109	CcSEcCtD
Rifabutin—Vomiting—Fluorouracil—pancreatic cancer	0.000297	0.00109	CcSEcCtD
Rifabutin—Dyspepsia—Docetaxel—pancreatic cancer	0.000296	0.00109	CcSEcCtD
Rifabutin—Hepatitis—Doxorubicin—pancreatic cancer	0.000296	0.00108	CcSEcCtD
Rifabutin—Rash—Fluorouracil—pancreatic cancer	0.000294	0.00108	CcSEcCtD
Rifabutin—Dermatitis—Fluorouracil—pancreatic cancer	0.000294	0.00108	CcSEcCtD
Rifabutin—Decreased appetite—Docetaxel—pancreatic cancer	0.000293	0.00107	CcSEcCtD
Rifabutin—Headache—Fluorouracil—pancreatic cancer	0.000292	0.00107	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000291	0.00106	CcSEcCtD
Rifabutin—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.000291	0.00106	CcSEcCtD
Rifabutin—Nausea—Irinotecan—pancreatic cancer	0.000289	0.00106	CcSEcCtD
Rifabutin—Immune system disorder—Epirubicin—pancreatic cancer	0.000289	0.00106	CcSEcCtD
Rifabutin—Pain—Docetaxel—pancreatic cancer	0.000288	0.00105	CcSEcCtD
Rifabutin—Nausea—Gemcitabine—pancreatic cancer	0.000282	0.00103	CcSEcCtD
Rifabutin—Feeling abnormal—Docetaxel—pancreatic cancer	0.000277	0.00102	CcSEcCtD
Rifabutin—Nausea—Fluorouracil—pancreatic cancer	0.000277	0.00101	CcSEcCtD
Rifabutin—Eye disorder—Doxorubicin—pancreatic cancer	0.000276	0.00101	CcSEcCtD
Rifabutin—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000275	0.00101	CcSEcCtD
Rifabutin—Flatulence—Epirubicin—pancreatic cancer	0.000274	0.001	CcSEcCtD
Rifabutin—Dysgeusia—Epirubicin—pancreatic cancer	0.000272	0.000998	CcSEcCtD
Rifabutin—Immune system disorder—Doxorubicin—pancreatic cancer	0.000267	0.000978	CcSEcCtD
Rifabutin—Abdominal pain—Docetaxel—pancreatic cancer	0.000266	0.000975	CcSEcCtD
Rifabutin—Body temperature increased—Docetaxel—pancreatic cancer	0.000266	0.000975	CcSEcCtD
Rifabutin—Anaemia—Epirubicin—pancreatic cancer	0.000257	0.000942	CcSEcCtD
Rifabutin—Flatulence—Doxorubicin—pancreatic cancer	0.000254	0.000929	CcSEcCtD
Rifabutin—Dysgeusia—Doxorubicin—pancreatic cancer	0.000252	0.000923	CcSEcCtD
Rifabutin—Leukopenia—Epirubicin—pancreatic cancer	0.000249	0.000912	CcSEcCtD
Rifabutin—Hypersensitivity—Docetaxel—pancreatic cancer	0.000248	0.000908	CcSEcCtD
Rifabutin—Asthenia—Docetaxel—pancreatic cancer	0.000241	0.000885	CcSEcCtD
Rifabutin—Convulsion—Epirubicin—pancreatic cancer	0.000241	0.000883	CcSEcCtD
Rifabutin—Pruritus—Docetaxel—pancreatic cancer	0.000238	0.000872	CcSEcCtD
Rifabutin—Anaemia—Doxorubicin—pancreatic cancer	0.000238	0.000871	CcSEcCtD
Rifabutin—Myalgia—Epirubicin—pancreatic cancer	0.000237	0.000867	CcSEcCtD
Rifabutin—Chest pain—Epirubicin—pancreatic cancer	0.000237	0.000867	CcSEcCtD
Rifabutin—Arthralgia—Epirubicin—pancreatic cancer	0.000237	0.000867	CcSEcCtD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000235	0.000862	CcSEcCtD
Rifabutin—Leukopenia—Doxorubicin—pancreatic cancer	0.00023	0.000844	CcSEcCtD
Rifabutin—Diarrhoea—Docetaxel—pancreatic cancer	0.00023	0.000844	CcSEcCtD
Rifabutin—Confusional state—Epirubicin—pancreatic cancer	0.000229	0.000838	CcSEcCtD
Rifabutin—Shock—Epirubicin—pancreatic cancer	0.000223	0.000818	CcSEcCtD
Rifabutin—Convulsion—Doxorubicin—pancreatic cancer	0.000223	0.000817	CcSEcCtD
Rifabutin—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000222	0.000814	CcSEcCtD
Rifabutin—Skin disorder—Epirubicin—pancreatic cancer	0.000221	0.000808	CcSEcCtD
Rifabutin—Arthralgia—Doxorubicin—pancreatic cancer	0.000219	0.000803	CcSEcCtD
Rifabutin—Chest pain—Doxorubicin—pancreatic cancer	0.000219	0.000803	CcSEcCtD
Rifabutin—Myalgia—Doxorubicin—pancreatic cancer	0.000219	0.000803	CcSEcCtD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000218	0.000797	CcSEcCtD
Rifabutin—Anorexia—Epirubicin—pancreatic cancer	0.000216	0.000793	CcSEcCtD
Rifabutin—Vomiting—Docetaxel—pancreatic cancer	0.000214	0.000784	CcSEcCtD
Rifabutin—Rash—Docetaxel—pancreatic cancer	0.000212	0.000777	CcSEcCtD
Rifabutin—Dermatitis—Docetaxel—pancreatic cancer	0.000212	0.000777	CcSEcCtD
Rifabutin—Confusional state—Doxorubicin—pancreatic cancer	0.000212	0.000776	CcSEcCtD
Rifabutin—Headache—Docetaxel—pancreatic cancer	0.000211	0.000772	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000207	0.000758	CcSEcCtD
Rifabutin—Shock—Doxorubicin—pancreatic cancer	0.000207	0.000757	CcSEcCtD
Rifabutin—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000206	0.000753	CcSEcCtD
Rifabutin—Insomnia—Epirubicin—pancreatic cancer	0.000205	0.000752	CcSEcCtD
Rifabutin—Skin disorder—Doxorubicin—pancreatic cancer	0.000204	0.000747	CcSEcCtD
Rifabutin—Paraesthesia—Epirubicin—pancreatic cancer	0.000204	0.000747	CcSEcCtD
Rifabutin—Dyspnoea—Epirubicin—pancreatic cancer	0.000202	0.000741	CcSEcCtD
Rifabutin—Anorexia—Doxorubicin—pancreatic cancer	0.0002	0.000733	CcSEcCtD
Rifabutin—Nausea—Docetaxel—pancreatic cancer	0.0002	0.000732	CcSEcCtD
Rifabutin—Dyspepsia—Epirubicin—pancreatic cancer	0.0002	0.000732	CcSEcCtD
Rifabutin—Decreased appetite—Epirubicin—pancreatic cancer	0.000197	0.000723	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000196	0.000718	CcSEcCtD
Rifabutin—Pain—Epirubicin—pancreatic cancer	0.000194	0.000711	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000191	0.000701	CcSEcCtD
Rifabutin—Insomnia—Doxorubicin—pancreatic cancer	0.00019	0.000696	CcSEcCtD
Rifabutin—Paraesthesia—Doxorubicin—pancreatic cancer	0.000189	0.000691	CcSEcCtD
Rifabutin—Dyspnoea—Doxorubicin—pancreatic cancer	0.000187	0.000686	CcSEcCtD
Rifabutin—Feeling abnormal—Epirubicin—pancreatic cancer	0.000187	0.000685	CcSEcCtD
Rifabutin—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000186	0.00068	CcSEcCtD
Rifabutin—Dyspepsia—Doxorubicin—pancreatic cancer	0.000185	0.000677	CcSEcCtD
Rifabutin—Decreased appetite—Doxorubicin—pancreatic cancer	0.000183	0.000669	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000181	0.000664	CcSEcCtD
Rifabutin—Pain—Doxorubicin—pancreatic cancer	0.00018	0.000658	CcSEcCtD
Rifabutin—Body temperature increased—Epirubicin—pancreatic cancer	0.000179	0.000657	CcSEcCtD
Rifabutin—Abdominal pain—Epirubicin—pancreatic cancer	0.000179	0.000657	CcSEcCtD
Rifabutin—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000173	0.000634	CcSEcCtD
Rifabutin—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000172	0.000629	CcSEcCtD
Rifabutin—Hypersensitivity—Epirubicin—pancreatic cancer	0.000167	0.000613	CcSEcCtD
Rifabutin—Body temperature increased—Doxorubicin—pancreatic cancer	0.000166	0.000608	CcSEcCtD
Rifabutin—Abdominal pain—Doxorubicin—pancreatic cancer	0.000166	0.000608	CcSEcCtD
Rifabutin—Asthenia—Epirubicin—pancreatic cancer	0.000163	0.000597	CcSEcCtD
Rifabutin—Pruritus—Epirubicin—pancreatic cancer	0.000161	0.000588	CcSEcCtD
Rifabutin—Diarrhoea—Epirubicin—pancreatic cancer	0.000155	0.000569	CcSEcCtD
Rifabutin—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000155	0.000567	CcSEcCtD
Rifabutin—Asthenia—Doxorubicin—pancreatic cancer	0.000151	0.000552	CcSEcCtD
Rifabutin—Pruritus—Doxorubicin—pancreatic cancer	0.000149	0.000544	CcSEcCtD
Rifabutin—Vomiting—Epirubicin—pancreatic cancer	0.000144	0.000529	CcSEcCtD
Rifabutin—HSP90AA1—Developmental Biology—MET—pancreatic cancer	0.000144	0.000594	CbGpPWpGaD
Rifabutin—Diarrhoea—Doxorubicin—pancreatic cancer	0.000144	0.000526	CcSEcCtD
Rifabutin—HSP90B1—Innate Immune System—PIK3CA—pancreatic cancer	0.000144	0.000591	CbGpPWpGaD
Rifabutin—Rash—Epirubicin—pancreatic cancer	0.000143	0.000524	CcSEcCtD
Rifabutin—Dermatitis—Epirubicin—pancreatic cancer	0.000143	0.000524	CcSEcCtD
Rifabutin—HSP90AA1—Signaling by ERBB2—HRAS—pancreatic cancer	0.000143	0.000586	CbGpPWpGaD
Rifabutin—Headache—Epirubicin—pancreatic cancer	0.000142	0.000521	CcSEcCtD
Rifabutin—HSP90AA1—Signaling by EGFR in Cancer—PIK3CA—pancreatic cancer	0.000142	0.000583	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—SHH—pancreatic cancer	0.000141	0.000579	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—NOTCH1—pancreatic cancer	0.000139	0.000572	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—IAPP—pancreatic cancer	0.000139	0.000571	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—PIK3CB—pancreatic cancer	0.000137	0.000564	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—BCL2L1—pancreatic cancer	0.000137	0.000562	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—DTX4—pancreatic cancer	0.000136	0.00056	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—GLI1—pancreatic cancer	0.000136	0.00056	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—TSC2—pancreatic cancer	0.000136	0.000559	CbGpPWpGaD
Rifabutin—CYP1A2—Arachidonic acid metabolism—PTGS2—pancreatic cancer	0.000136	0.000558	CbGpPWpGaD
Rifabutin—Nausea—Epirubicin—pancreatic cancer	0.000135	0.000494	CcSEcCtD
Rifabutin—HSP90AA1—Cellular responses to stress—VEGFA—pancreatic cancer	0.000134	0.000552	CbGpPWpGaD
Rifabutin—Vomiting—Doxorubicin—pancreatic cancer	0.000134	0.000489	CcSEcCtD
Rifabutin—HSP90AA1—Disease—HSPA1B—pancreatic cancer	0.000133	0.000549	CbGpPWpGaD
Rifabutin—HSP90B1—Innate Immune System—HRAS—pancreatic cancer	0.000133	0.000546	CbGpPWpGaD
Rifabutin—HSP90AA1—Cellular responses to stress—STAT3—pancreatic cancer	0.000133	0.000546	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—NRP1—pancreatic cancer	0.000133	0.000545	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—PPP2R5B—pancreatic cancer	0.000133	0.000545	CbGpPWpGaD
Rifabutin—Rash—Doxorubicin—pancreatic cancer	0.000132	0.000485	CcSEcCtD
Rifabutin—Dermatitis—Doxorubicin—pancreatic cancer	0.000132	0.000485	CcSEcCtD
Rifabutin—Headache—Doxorubicin—pancreatic cancer	0.000132	0.000482	CcSEcCtD
Rifabutin—HSP90AA1—Metabolism—GLP1R—pancreatic cancer	0.000131	0.00054	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—PPARG—pancreatic cancer	0.000131	0.000539	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by EGFR in Cancer—HRAS—pancreatic cancer	0.000131	0.000539	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle, Mitotic—RB1—pancreatic cancer	0.00013	0.000535	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—DPYD—pancreatic cancer	0.000129	0.000532	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—HEY2—pancreatic cancer	0.000128	0.000525	CbGpPWpGaD
Rifabutin—HSP90AA1—Axon guidance—MMP9—pancreatic cancer	0.000127	0.000522	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by ERBB2—AKT1—pancreatic cancer	0.000126	0.000518	CbGpPWpGaD
Rifabutin—Nausea—Doxorubicin—pancreatic cancer	0.000125	0.000457	CcSEcCtD
Rifabutin—HSP90AA1—Signaling Pathways—GAST—pancreatic cancer	0.000125	0.000513	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—NFKBIA—pancreatic cancer	0.000124	0.00051	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—CD44—pancreatic cancer	0.000123	0.000505	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—SLC2A2—pancreatic cancer	0.000123	0.000504	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—CTNNB1—pancreatic cancer	0.000122	0.0005	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—MMP2—pancreatic cancer	0.00012	0.000495	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—JAG1—pancreatic cancer	0.000119	0.000491	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—IFNA1—pancreatic cancer	0.000119	0.000489	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—EGF—pancreatic cancer	0.000119	0.000488	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—PTEN—pancreatic cancer	0.000119	0.000488	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—SCT—pancreatic cancer	0.000118	0.000486	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—HEY1—pancreatic cancer	0.000118	0.000486	CbGpPWpGaD
Rifabutin—HSP90B1—Innate Immune System—AKT1—pancreatic cancer	0.000117	0.000482	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—pancreatic cancer	0.000117	0.000482	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—SRC—pancreatic cancer	0.000117	0.000482	CbGpPWpGaD
Rifabutin—HSP90AA1—Axon guidance—SRC—pancreatic cancer	0.000117	0.000481	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle—RB1—pancreatic cancer	0.000116	0.000478	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by EGFR in Cancer—AKT1—pancreatic cancer	0.000116	0.000476	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle, Mitotic—CDKN2A—pancreatic cancer	0.000114	0.00047	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—pancreatic cancer	0.000114	0.00047	CbGpPWpGaD
Rifabutin—HSP90AA1—Axon guidance—VEGFA—pancreatic cancer	0.000114	0.000468	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—CD44—pancreatic cancer	0.000113	0.000466	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—pancreatic cancer	0.000113	0.000464	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CCK—pancreatic cancer	0.000113	0.000464	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—HSPA1A—pancreatic cancer	0.000113	0.000463	CbGpPWpGaD
Rifabutin—HSP90AA1—Axon guidance—NRAS—pancreatic cancer	0.000112	0.000463	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—IFNA2—pancreatic cancer	0.000111	0.000455	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—SRC—pancreatic cancer	0.00011	0.000452	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CNR2—pancreatic cancer	0.00011	0.000452	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—GLP1R—pancreatic cancer	0.00011	0.000452	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CCKAR—pancreatic cancer	0.000108	0.000444	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—STAT3—pancreatic cancer	0.000106	0.000436	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—NRAS—pancreatic cancer	0.000106	0.000435	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—PIK3CD—pancreatic cancer	0.000105	0.000434	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—MYC—pancreatic cancer	0.000105	0.000432	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—pancreatic cancer	0.000105	0.000431	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—JAG2—pancreatic cancer	0.000105	0.000431	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—MEN1—pancreatic cancer	0.000103	0.000425	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—pancreatic cancer	0.000103	0.000423	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—pancreatic cancer	0.000103	0.000423	CbGpPWpGaD
Rifabutin—HSP90AA1—Axon guidance—EGFR—pancreatic cancer	0.000102	0.000422	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle—CDKN2A—pancreatic cancer	0.000102	0.00042	CbGpPWpGaD
Rifabutin—HSP90AA1—Cellular responses to stress—TP53—pancreatic cancer	0.000101	0.000417	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—SHH—pancreatic cancer	9.85e-05	0.000405	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—NOTCH4—pancreatic cancer	9.79e-05	0.000403	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—pancreatic cancer	9.78e-05	0.000403	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—pancreatic cancer	9.78e-05	0.000403	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—IAPP—pancreatic cancer	9.73e-05	0.0004	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—pancreatic cancer	9.7e-05	0.000399	CbGpPWpGaD
Rifabutin—HSP90AA1—Axon guidance—KRAS—pancreatic cancer	9.68e-05	0.000398	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle, Mitotic—CCND1—pancreatic cancer	9.65e-05	0.000397	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—EGFR—pancreatic cancer	9.63e-05	0.000396	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—CD44—pancreatic cancer	9.49e-05	0.000391	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—PTHLH—pancreatic cancer	9.34e-05	0.000384	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—PTCH1—pancreatic cancer	9.34e-05	0.000384	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—CTNNB1—pancreatic cancer	9.23e-05	0.00038	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—PIK3CB—pancreatic cancer	9.19e-05	0.000378	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—GCG—pancreatic cancer	9.1e-05	0.000374	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—KRAS—pancreatic cancer	9.1e-05	0.000374	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—MMP9—pancreatic cancer	9.05e-05	0.000372	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—SMAD4—pancreatic cancer	8.95e-05	0.000368	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—HES1—pancreatic cancer	8.74e-05	0.00036	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle—CCND1—pancreatic cancer	8.63e-05	0.000355	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—STK11—pancreatic cancer	8.56e-05	0.000352	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—SST—pancreatic cancer	8.54e-05	0.000351	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—PIK3CA—pancreatic cancer	8.36e-05	0.000344	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—JAG1—pancreatic cancer	8.36e-05	0.000344	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—SRC—pancreatic cancer	8.34e-05	0.000343	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—NOTCH3—pancreatic cancer	8.32e-05	0.000342	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—pancreatic cancer	8.25e-05	0.000339	CbGpPWpGaD
Rifabutin—HSP90AA1—Axon guidance—HRAS—pancreatic cancer	8.23e-05	0.000338	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—CTNNB1—pancreatic cancer	8.15e-05	0.000335	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—VEGFA—pancreatic cancer	8.12e-05	0.000334	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—STAT3—pancreatic cancer	8.04e-05	0.000331	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—NRAS—pancreatic cancer	8.02e-05	0.00033	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—BCL2L1—pancreatic cancer	7.96e-05	0.000328	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—PTEN—pancreatic cancer	7.94e-05	0.000327	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—TSC2—pancreatic cancer	7.91e-05	0.000326	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CNR1—pancreatic cancer	7.88e-05	0.000324	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle, Mitotic—MYC—pancreatic cancer	7.74e-05	0.000318	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—HRAS—pancreatic cancer	7.73e-05	0.000318	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—TERT—pancreatic cancer	7.66e-05	0.000315	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—GCG—pancreatic cancer	7.61e-05	0.000313	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—TGFB1—pancreatic cancer	7.46e-05	0.000307	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—SRC—pancreatic cancer	7.37e-05	0.000303	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—TYMS—pancreatic cancer	7.36e-05	0.000303	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—HIF1A—pancreatic cancer	7.32e-05	0.000301	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—EGFR—pancreatic cancer	7.31e-05	0.000301	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—TSC2—pancreatic cancer	7.3e-05	0.000301	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—AGTR1—pancreatic cancer	7.26e-05	0.000299	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—NFKBIA—pancreatic cancer	7.22e-05	0.000297	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—STK11—pancreatic cancer	7.16e-05	0.000294	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—APOE—pancreatic cancer	7.15e-05	0.000294	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—NRAS—pancreatic cancer	7.09e-05	0.000292	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—TNF—pancreatic cancer	6.96e-05	0.000286	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle—MYC—pancreatic cancer	6.92e-05	0.000285	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—EGF—pancreatic cancer	6.91e-05	0.000284	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—KRAS—pancreatic cancer	6.91e-05	0.000284	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—AKT1—pancreatic cancer	6.83e-05	0.000281	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—NOTCH1—pancreatic cancer	6.6e-05	0.000271	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—EGFR—pancreatic cancer	6.46e-05	0.000266	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—CDH1—pancreatic cancer	6.43e-05	0.000265	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—EGF—pancreatic cancer	6.38e-05	0.000262	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—SMAD4—pancreatic cancer	6.27e-05	0.000258	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—PIK3CD—pancreatic cancer	6.14e-05	0.000253	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—HES1—pancreatic cancer	6.12e-05	0.000252	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—KRAS—pancreatic cancer	6.1e-05	0.000251	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—APOE—pancreatic cancer	5.99e-05	0.000246	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—HRAS—pancreatic cancer	5.87e-05	0.000242	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle—TP53—pancreatic cancer	5.68e-05	0.000234	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—PIK3CD—pancreatic cancer	5.67e-05	0.000233	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—PIK3CA—pancreatic cancer	5.6e-05	0.000231	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—PIK3CG—pancreatic cancer	5.4e-05	0.000222	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—TERT—pancreatic cancer	5.36e-05	0.000221	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—PIK3CB—pancreatic cancer	5.35e-05	0.00022	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—PPARG—pancreatic cancer	5.21e-05	0.000215	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—HRAS—pancreatic cancer	5.18e-05	0.000213	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—AKT1—pancreatic cancer	5.18e-05	0.000213	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—HIF1A—pancreatic cancer	5.13e-05	0.000211	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—TSC2—pancreatic cancer	5.12e-05	0.00021	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—APOE—pancreatic cancer	5.01e-05	0.000206	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—PIK3CB—pancreatic cancer	4.94e-05	0.000203	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—KDR—pancreatic cancer	4.9e-05	0.000202	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—PTGS2—pancreatic cancer	4.9e-05	0.000202	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—PIK3CD—pancreatic cancer	4.75e-05	0.000195	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—CTNNB1—pancreatic cancer	4.75e-05	0.000195	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—NFKBIA—pancreatic cancer	4.66e-05	0.000192	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—PTEN—pancreatic cancer	4.63e-05	0.00019	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—NOTCH1—pancreatic cancer	4.62e-05	0.00019	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—AKT1—pancreatic cancer	4.58e-05	0.000188	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PRSS1—pancreatic cancer	4.52e-05	0.000186	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—PIK3CG—pancreatic cancer	4.52e-05	0.000186	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—EGF—pancreatic cancer	4.47e-05	0.000184	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—CTNNB1—pancreatic cancer	4.38e-05	0.00018	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—SRC—pancreatic cancer	4.29e-05	0.000177	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—PTEN—pancreatic cancer	4.27e-05	0.000176	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—PIK3CB—pancreatic cancer	4.14e-05	0.00017	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—STAT3—pancreatic cancer	4.14e-05	0.00017	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—NRAS—pancreatic cancer	4.13e-05	0.00017	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—PTGS2—pancreatic cancer	4.1e-05	0.000169	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—PIK3CD—pancreatic cancer	3.97e-05	0.000163	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—SRC—pancreatic cancer	3.96e-05	0.000163	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—ARG2—pancreatic cancer	3.92e-05	0.000161	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—STAT3—pancreatic cancer	3.82e-05	0.000157	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—NRAS—pancreatic cancer	3.81e-05	0.000157	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—EGFR—pancreatic cancer	3.76e-05	0.000155	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—PTEN—pancreatic cancer	3.58e-05	0.000147	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—KRAS—pancreatic cancer	3.55e-05	0.000146	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—MYC—pancreatic cancer	3.55e-05	0.000146	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—TGFB1—pancreatic cancer	3.54e-05	0.000146	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PRSS1—pancreatic cancer	3.49e-05	0.000144	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—EGFR—pancreatic cancer	3.47e-05	0.000143	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—PIK3CB—pancreatic cancer	3.46e-05	0.000142	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—TYMP—pancreatic cancer	3.43e-05	0.000141	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CXCL8—pancreatic cancer	3.33e-05	0.000137	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—KRAS—pancreatic cancer	3.28e-05	0.000135	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—PIK3CA—pancreatic cancer	3.26e-05	0.000134	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CASP3—pancreatic cancer	3.18e-05	0.000131	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CCND1—pancreatic cancer	3.1e-05	0.000128	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CTNNB1—pancreatic cancer	3.07e-05	0.000126	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—ARG2—pancreatic cancer	3.03e-05	0.000124	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—HRAS—pancreatic cancer	3.02e-05	0.000124	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—PIK3CA—pancreatic cancer	3.01e-05	0.000124	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—MMP9—pancreatic cancer	3.01e-05	0.000124	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—PTEN—pancreatic cancer	2.99e-05	0.000123	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	2.83e-05	0.000116	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—HRAS—pancreatic cancer	2.79e-05	0.000115	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—SRC—pancreatic cancer	2.77e-05	0.000114	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—GLP1R—pancreatic cancer	2.76e-05	0.000114	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—DPYD—pancreatic cancer	2.72e-05	0.000112	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—VEGFA—pancreatic cancer	2.7e-05	0.000111	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—STAT3—pancreatic cancer	2.68e-05	0.00011	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—NRAS—pancreatic cancer	2.67e-05	0.00011	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—AKT1—pancreatic cancer	2.67e-05	0.00011	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—TYMP—pancreatic cancer	2.64e-05	0.000109	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—SLC2A2—pancreatic cancer	2.58e-05	0.000106	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	2.55e-05	0.000105	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—PIK3CA—pancreatic cancer	2.52e-05	0.000104	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—MYC—pancreatic cancer	2.49e-05	0.000102	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—TGFB1—pancreatic cancer	2.48e-05	0.000102	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	2.46e-05	0.000101	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—AKT1—pancreatic cancer	2.46e-05	0.000101	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—EGFR—pancreatic cancer	2.43e-05	0.0001	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—KRAS—pancreatic cancer	2.3e-05	9.45e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	2.24e-05	9.23e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—GLP1R—pancreatic cancer	2.13e-05	8.77e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—PIK3CA—pancreatic cancer	2.11e-05	8.68e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—DPYD—pancreatic cancer	2.1e-05	8.63e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—AKT1—pancreatic cancer	2.06e-05	8.48e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—TP53—pancreatic cancer	2.04e-05	8.4e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—CD44—pancreatic cancer	2e-05	8.22e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	1.99e-05	8.19e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	1.96e-05	8.05e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—HRAS—pancreatic cancer	1.95e-05	8.03e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	1.94e-05	7.97e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—GCG—pancreatic cancer	1.91e-05	7.88e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—STK11—pancreatic cancer	1.8e-05	7.41e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—AKT1—pancreatic cancer	1.72e-05	7.09e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	1.69e-05	6.95e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—TYMS—pancreatic cancer	1.55e-05	6.37e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—CD44—pancreatic cancer	1.54e-05	6.34e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—GCG—pancreatic cancer	1.48e-05	6.08e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—STK11—pancreatic cancer	1.39e-05	5.72e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—APOE—pancreatic cancer	1.26e-05	5.18e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—TYMS—pancreatic cancer	1.19e-05	4.92e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.19e-05	4.9e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PIK3CG—pancreatic cancer	1.14e-05	4.68e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PPARG—pancreatic cancer	1.1e-05	4.51e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PIK3CD—pancreatic cancer	9.99e-06	4.11e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—APOE—pancreatic cancer	9.72e-06	4e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	8.77e-06	3.61e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PIK3CB—pancreatic cancer	8.71e-06	3.58e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PTGS2—pancreatic cancer	8.63e-06	3.55e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PPARG—pancreatic cancer	8.46e-06	3.48e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	7.71e-06	3.17e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PTEN—pancreatic cancer	7.52e-06	3.1e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	6.72e-06	2.77e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PTGS2—pancreatic cancer	6.66e-06	2.74e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PTEN—pancreatic cancer	5.81e-06	2.39e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PIK3CA—pancreatic cancer	5.31e-06	2.18e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—AKT1—pancreatic cancer	4.34e-06	1.78e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	4.1e-06	1.69e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—AKT1—pancreatic cancer	3.35e-06	1.38e-05	CbGpPWpGaD
